Oppenheimer Maintains Outperform on Universal Display, Raises Price Target to $160

Oppenheimer analyst Martin Yang maintains Universal Display (NASDAQ:OLED) with a Outperform and raises the price target from $150 to $160.

byBenzinga Newsdesk

February 24, 2023

1 minute read

Oppenheimer analyst Martin Yang maintains Universal Display (NASDAQ:OLED) with a Outperform and raises the price target from $150 to $160.

SVB Leerink Maintains Market Perform on Ionis Pharmaceuticals, Lowers Price Target to $36

By Benzinga Newsdesk

December 8, 9:39 AM

SVB Leerink analyst Mani Foroohar maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and lowers the price target from $39 to $36.

IONS

Acadia’s Non-Opioid Post-Operative Pain Med Flunks In Mid-Stage Study

By Vandana Singh

April 19, 6:10 AM

Acadia Pharmaceuticals Inc (NASDAQ: ACAD) announced topline results from a Phase 2 trial evaluating the efficacy and safety of ACP-044 for acute pain following bunionectomy surgery.

ACAD

‘Can’t Stop People From Making Ponzis On Blockchains,’ Say MetaMask Founders

By Samyuktha Sriram

July 15, 4:29 AM

Dan Finlay and Aaron Davis, co-founders of Ethereum (CRYPTO: ETH) wallet MetaMask, say there is only so much the platform can do to stop bad actors in the cryptocurrency sector.

AAPL

Adastra Steps Into Magic Mushrooms! Gets Dealer’s License For Psilocybin And Psilocin

By Vuk Zdinjak

August 31, 10:00 AM

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) has received its Controlled Drug and Substances Dealer's License on August 24, 2022. This license allows Adastra to process psilocybin and psilocin, the active compounds derived from psychedelic mushrooms.

CSE:XTRX

Oppenheimer Maintains Outperform on Universal Display, Raises Price Target to $160

Related Posts

SVB Leerink Maintains Market Perform on Ionis Pharmaceuticals, Lowers Price Target to $36

Acadia’s Non-Opioid Post-Operative Pain Med Flunks In Mid-Stage Study

‘Can’t Stop People From Making Ponzis On Blockchains,’ Say MetaMask Founders

Adastra Steps Into Magic Mushrooms! Gets Dealer’s License For Psilocybin And Psilocin